Chargement de la fiche…
Chargement de la fiche…
Vous êtes Dr Luc Simon ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Luc Simon est rhumatologue à Chaumont (52000). Il consulte à CABINET DU DR Luc SIMON, 31 AVENUE CARNOT, 52000 Chaumont. Il est conventionné en secteur 1.
Consulter
Dr Luc Simon, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine · CES Rhumatologie · Attestation études Exploration fonctionnelle neuromusculaire · DU Réparation juridique du dommage corporel — Capacité / certificat d'études spéciales
DU Réparation juridique du dommage corporel
Formation à l'expertise médicale dans les procédures juridiques (accidents du travail, AT/MP, indemnisation). Le rhumato expertise les conséquences fonctionnelles.
Plusieurs universités françaises
Les plus citées
2021Seminars in arthritis and rheumatism179 citations
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis
2023Arthritis research & therapy52 citations
Interleukin-1β inhibitors for the management of acute gout flares: a systematic literature review
2020Osteoarthritis and cartilage open40 citations
Disease modification in osteoarthritis; pathways to drug approval
En bref
Dr Luc Simon consulte à CABINET DU DR Luc SIMON, 31 AVENUE CARNOT, 52000 Chaumont. Adresses issues de l'Annuaire Santé (ANS).
Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Oui, en secteur 1 : tarifs conventionnés, sans dépassement d'honoraires (source : Assurance Maladie).
Non, selon les données de l'Assurance Maladie.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Chaumont, j'accompagne…
Exemple : vous choisissez vos propres domaines.
2025Osteoarthritis and cartilage openPubMed
Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?
2024The Lancet. RheumatologyPubMed
Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial
2024Osteoarthritis and cartilage openPubMed
Toward designing human intervention studies to prevent osteoarthritis after knee injury: A report from an interdisciplinary OARSI 2023 workshop
2023Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAPubMed
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
2023Arthritis care & researchPubMed
Biopsychosocial Rehabilitation for Inflammatory Arthritis and Osteoarthritis Patients: A Systematic Review and Meta-Analysis of Randomized Trials
2022Seminars in arthritis and rheumatismPubMed
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit
2021Osteoarthritis and cartilagePubMed
Critical appraisal of intra-articular glucocorticoid injections for symptomatic osteoarthritis of the knee
2020Seminars in arthritis and rheumatismPubMed
A novel diclofenac gel (AMZ001) applied once or twice daily in subjects with painful knee osteoarthritis: A randomized, placebo-controlled clinical trial
2020Osteoarthritis and cartilage openPubMed
Disease modification in osteoarthritis; pathways to drug approval
2025Seminars in arthritis and rheumatismPubMed
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set
2025Lupus science & medicinePubMed
Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study
2024Seminars in arthritis and rheumatismPubMed
OMERACT systemic lupus erythematosus domain survey
2024Seminars in arthritis and rheumatismPubMed
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set
2023Nature reviews. RheumatologyPubMed
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce
2023LupusPubMed
Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group
2022Rheumatology (Oxford, England)PubMed
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?
2021Rheumatology (Oxford, England)PubMed
What are the domains and outcome measures used in the existing neuropsychiatric systemic lupus erythematosus literature?
2021Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseasesPubMed
The Patients' Perspective of Important Glucocorticoid Effects: A Nominal Group Study Among Patients With Systemic Lupus Erythematosus and Myositis
2026Seminars in arthritis and rheumatismPubMed
Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study
2022ACR open rheumatologyPubMed
Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib
2021Rheumatology and therapyPubMed
Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis
2021Seminars in arthritis and rheumatismPubMed
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis
2026Seminars in arthritis and rheumatismPubMed
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement
2023Seminars in arthritis and rheumatismPubMed
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group
2021Seminars in arthritis and rheumatismPubMed
Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group
2026Seminars in arthritis and rheumatismPubMed
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement
2023Seminars in arthritis and rheumatismPubMed
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group
2022PLoS neglected tropical diseasesPubMed
Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review
2021Seminars in arthritis and rheumatismPubMed
Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group
2025 · Article
Respiratory motion management for external radiotherapy: 2025 update
2017 · Article
Variants of β-casofensin, a bioactive milk peptide, differently modulate the intestinal barrier: In vivo and ex vivo studies in rats
2015 · Article
Virtual bolus for total body irradiation treated with helical tomotherapy
2013 · Article
Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost.
2009 · Article
[Clinical prediction rule for diagnosing deep vein thrombosis in primary care].
2002 · Article
The influence of metabolic network structures and energy requirements on xanthan gum yields
2001 · Article
Kinetic analysis of growth and xanthan gum production with Xanthomonas campestris on sucrose, using sequentially consumed nitrogen sources
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.